Literature DB >> 16907906

Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC).

A K Chauhan1, T L Moore.   

Abstract

The complement regulatory (CR) proteins clusterin and vitronectin bind to the membrane attack complex (MAC) and thus prevent cytolysis. In this report, we demonstrate the presence of both of these CR proteins on MAC bound to circulating immune complexes (CIC). We measured the amount of clusterin and vitronectin on MAC in plasma, also referred to as soluble MAC (SMAC), as well as on MAC bound to CIC (MAC-CIC), using antibody directed to polymerized C9 in systemic lupus erythematosus (SLE) patients. We observed a strong correlation among the quantities of SMAC and MAC-CIC. The amount of both clusterin and vitronectin associated with MAC-CIC was two- to threefold higher in comparison to the SMAC. Patients with high levels of clusterin and vitronectin demonstrated renal involvement. We hypothesize that these complement regulatory proteins besides regulating the insertion of MAC play other critical roles, in disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16907906      PMCID: PMC1809708          DOI: 10.1111/j.1365-2249.2006.03135.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Analysis of the cell infiltrate and expression of matrix metalloproteinases and granzyme B in paired synovial biopsy specimens from the cartilage-pannus junction in patients with RA.

Authors:  T J Smeets; M C Kraan; S Galjaard; P P Youssef; M D Smith; P P Tak
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

Review 2.  Cell signals transduced by complement.

Authors:  Osnat Bohana-Kashtan; Lea Ziporen; Natalie Donin; Sarah Kraus; Zvi Fishelson
Journal:  Mol Immunol       Date:  2004-07       Impact factor: 4.407

3.  Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo.

Authors:  Aldo Dobrina; Mario Pausa; Fabio Fischetti; Roberta Bulla; Elena Vecile; Elisabetta Ferrero; Alberto Mantovani; Francesco Tedesco
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

4.  The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA).

Authors:  P P Tak; L Spaeny-Dekking; M C Kraan; F C Breedveld; C J Froelich; C E Hack
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

Review 5.  Complement and apoptosis.

Authors:  Z Fishelson; G Attali; D Mevorach
Journal:  Mol Immunol       Date:  2001-08       Impact factor: 4.407

6.  Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state.

Authors:  S Poon; S B Easterbrook-Smith; M S Rybchyn; J A Carver; M R Wilson
Journal:  Biochemistry       Date:  2000-12-26       Impact factor: 3.162

7.  The membrane attack complex of complement induces caspase activation and apoptosis.

Authors:  Alma J Nauta; Mohamed R Daha; Odette Tijsma; Bob van de Water; Francesco Tedesco; Anja Roos
Journal:  Eur J Immunol       Date:  2002-03       Impact factor: 5.532

8.  [Terminal complement complex (TCC) levels in urine in patients with renal diseases].

Authors:  K Yasuda
Journal:  Hokkaido Igaku Zasshi       Date:  2001-03

Review 9.  Inhibition of terminal complement: a novel therapeutic approach for the treatment of systemic lupus erythematosus.

Authors:  R P Rother; C F Mojcik; E W McCroskery
Journal:  Lupus       Date:  2004       Impact factor: 2.911

10.  SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.

Authors:  Y Y Chiu; R M Nisihara; R Würzner; M Kirschfink; I J de Messias-Reason
Journal:  J Investig Allergol Clin Immunol       Date:  1998 Jul-Aug       Impact factor: 4.333

View more
  21 in total

Review 1.  Protein engineering to target complement evasion in cancer.

Authors:  Darrick Carter; André Lieber
Journal:  FEBS Lett       Date:  2013-11-14       Impact factor: 4.124

2.  T cell activation by terminal complex of complement and immune complexes.

Authors:  Anil K Chauhan; Terry L Moore
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

3.  The iron-regulated surface determinant B (IsdB) protein from Staphylococcus aureus acts as a receptor for the host protein vitronectin.

Authors:  Giampiero Pietrocola; Angelica Pellegrini; Mariangela J Alfeo; Loredana Marchese; Timothy J Foster; Pietro Speziale
Journal:  J Biol Chem       Date:  2020-06-04       Impact factor: 5.157

4.  [Proteome analysis of undiluted vitreous humor in patients with branch retinal vein occlusion].

Authors:  I Dacheva; M Reich; M Nobl; K Ceglowska; J Wasiak; J Siwy; P Zürbig; H Mischak; F H J Koch; J Kopitz; F T A Kretz; T Tandogan; G U Auffarth; M J Koss
Journal:  Ophthalmologe       Date:  2018-03       Impact factor: 1.059

5.  Pathogenic Leptospira species acquire factor H and vitronectin via the surface protein LcpA.

Authors:  Ludmila Bezerra da Silva; Lidia Dos Santos Miragaia; Leandro Carvalho Dantas Breda; Cecilia Mari Abe; Mariana Costa Braga Schmidt; Ana Maria Moro; Denize Monaris; Jonas Nascimento Conde; Mihály Józsi; Lourdes Isaac; Patrícia Antônia Estima Abreu; Angela Silva Barbosa
Journal:  Infect Immun       Date:  2014-12-22       Impact factor: 3.441

6.  Induced expression of FcγRIIIa (CD16a) on CD4+ T cells triggers generation of IFN-γhigh subset.

Authors:  Anil K Chauhan; Chen Chen; Terry L Moore; Richard J DiPaolo
Journal:  J Biol Chem       Date:  2015-01-02       Impact factor: 5.157

7.  Immune complexes and late complement proteins trigger activation of Syk tyrosine kinase in human CD4(+) T cells.

Authors:  A K Chauhan; T L Moore
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

8.  Causes of alternative pathway dysregulation in dense deposit disease.

Authors:  Yuzhou Zhang; Nicole C Meyer; Kai Wang; Carla Nishimura; Kathy Frees; Michael Jones; Louis M Katz; Sanjeev Sethi; Richard J H Smith
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

9.  Proteomic analysis of electronegative low-density lipoprotein.

Authors:  Cristina Bancells; Francesc Canals; Sònia Benítez; Nuria Colomé; Josep Julve; Jordi Ordóñez-Llanos; José Luis Sánchez-Quesada
Journal:  J Lipid Res       Date:  2010-08-10       Impact factor: 5.922

10.  Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway.

Authors:  Sanjeev Sethi; Jeffrey D Gamez; Julie A Vrana; Jason D Theis; H Robert Bergen; Peter F Zipfel; Ahmet Dogan; Richard J H Smith
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.